1. Li Wang, et al. 2024 EHA, poster P2074 2. Eyre TA, Riches JC. The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives. Cancers (Basel) 20...
[5] Nizar J Bahlis, et al. EHA 2023. Abstract S192 [6] Damiette Smit, et al. ASCO 2023. Oral Presentation #8003 [7] Maria-Victoria Mateos, et al. EHA 2023. Abstract S190 [8] Cohen YC, et al. ASCO 2023....
Please note that the submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session at the time assigned by the Scientific Program Committee (SPC). We, therefore, recommend that submitter of an abstr...
Please note that the submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session at the time assigned by the Scientific Program Committee (SPC). We, therefore, recommend that submitter of an abstr...
Results from the MajesTEC-1 study evaluating TECVAYLI® in patients with high-risk relapsed or refractory multiple myeloma, and the clinical benefit and durability of TECVAYLI® (Poster Abstract #P923) B-Cell Malignancies at ASC...